No products in the cart.
Description
PRODUCT DESCRIPTION:
Ifosfamide is a nitrogen mustard alkylating agent used in the treatment of various solid tumors and hematologic malignancies.
It is especially effective in pediatric sarcomas, testicular cancer, and lymphomas.
Supplied in sterile pre-filled syringes, this ready-to-administer format ensures convenience, precision, and reduced risk of handling errors in oncology settings.
Formulation & Presentation:
- Dosage Form: Sterile Injectable
- Presentation: Both in Lyophilized & Pre-Filled Syringe (customizable as per market demand)
- Available Strengths:
- 1 GM
- 2 GM
- Route of Administration: Intravenous after dilution or as per clinical indication and severity. Reconstituted as per protocol Intravenous infusion. To be administered under supervision of a qualified oncologist. (As per physician’s discretion or decision) Administered as continuous infusion, typically as part of combination chemotherapy regimens
Therapeutic Indications:
- Testicular germ cell tumors
- Soft tissue sarcomas
- Lymphomas
- Osteosarcoma
- Cervical, ovarian, and lung cancers (off-label combinations)
- Pediatric cancers (Ewing’s sarcoma, rhabdomyosarcoma)
Side Effects:
- COMMON:
- Nausea and vomiting
- Myelosuppression (neutropenia, anemia, thrombocytopenia)
- Alopecia
- Fatigue
- Hematuria
- SERIOUS (RARE):
- Hemorrhagic cystitis (risk reduced with mesna co-administration)
- Neurotoxicity (encephalopathy, confusion)
- Renal impairment
- Infusion reactions
- Secondary malignancies (long-term risk)
- PRECAUTIONS:
- Must be co-administered with Mesna to prevent urotoxicity
- Monitor renal, hepatic, and neurological parameters closely
- Ensure cytotoxic handling precautions during preparation and disposal
- Adequate hydration required to reduce bladder toxicity
- Contraindicated in patients with severe bone marrow suppression or existing encephalopathy
Be the first to review “Ifosfamide Inj 1 GM, 2 GM, Pre-Filled Syringe”
TECHNICAL INFORMATION
Product Specifications
- HSN Code: To be assigned per international classification standards & import jurisdiction
- Weight: Approx. 40g per Carton (With Packaging)
- Dimensions: 15 x 1 x 8 CMS
- Shelf Life: 24 to 36 months under recommended storage conditions from date of manufacture or as per label specifications
- Storage:
- Pre-Filled Syringes: Store below 2°C–8°C
- Lyophilized Injection: Store below 25°C
- Do not freeze. Requires cold-chain logistics. Protect from moisture and direct sunlight. Use strictly as per label guidelines.
Regulatory Status & Supply Information
- Regulatory Status: WHO-GMP Compliant Manufacturing. COA, MSDS, Stability Data, Manufacturing Batch Record, and Dossier Support available on request
- Export Dossiers: Available in CTD/eCTD formats
- Stability: Compliant
- MOQ: Negotiable based on market & registration status
- Export Options: Available for private label, institutional supply, or branded export
Who Should Source This Product?
- Government procurement bodies sourcing cytotoxic agents for oncology programs
- Cancer hospitals & infusion clinics requiring pre-measured sterile formulations
- NGOs & humanitarian institutions ensuring access to quality cancer care
- Importers in LATAM, Africa, and South Asia managing oncology pipelines
- Specialty distributors focusing on pediatric oncology and rare cancer segments
Why Source from PHARMET?
- Single-window sourcing for diverse pharma needs
- Export-ready documentation & regulatory support
- Adaptable documentation support for effective registration in target countries
- Trusted consortium network simplifying India's pharma supply chain
- Multiple approved manufacturers for best fit in import country
- Audited, compliant manufacturing network across India
- Flexible branding, packaging & formulation options
- End-to-end logistics & export assistance
- Deep expertise in specialty injectables & regulated formulations
Contact Details
- Email: hello@pharmet.io
- Phone/WhatsApp: +91 9999091881
- Website: www.pharmet.io
Reviews
There are no reviews yet.